{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:04:47Z","timestamp":1794405887960,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":47,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642814907","type":"print"},{"value":"9783642814884","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1980]]},"DOI":"10.1007\/978-3-642-81488-4_15","type":"book-chapter","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:37:49Z","timestamp":1323218269000},"page":"107-123","source":"Crossref","is-referenced-by-count":113,"title":["Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)"],"prefix":"10.1007","author":[{"given":"C.","family":"Paoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Le Pecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dat-Xuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Juret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rouesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/pgmj.51.592.103","volume":"51","author":"BM Ansari","year":"1975","unstructured":"Ansari BM, Thompson EN (1975) Methoxy 9 ellipticine lactate in refractory acute myeloid leukemia. Postgrad Med J 51:103\u2013105","journal-title":"Postgrad Med J"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0300-9084(78)80645-2","volume":"60","author":"C Auclair","year":"1978","unstructured":"Auclair C, Gouyette A, Paoletti C (1978) Peroxydases catalyzed oxidation of the antitumor drug 9-hydroxy ellipticine. Abstract Coordination Chem and Cancer Chemother Meeting, Toulouse, July 24\u201326, 1978. Biochimie 60:1073","journal-title":"Biochimie"},{"key":"15_CR3","first-page":"1745","volume":"38","author":"NR Bachur","year":"1978","unstructured":"Bachur NR, Gordon SL, Gee MV (1978) A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38:1745\u20131750","journal-title":"Cancer Res"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1073\/pnas.76.2.954","volume":"76","author":"NR Bachur","year":"1979","unstructured":"Bachur NR, Gordon SL, Gee MV, Kon H (1979) NADPH cytochrome P450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76:954\u2013957","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-9556(25)06294-4","volume":"6","author":"AR Branfman","year":"1978","unstructured":"Branfman AR, Bruni RJ, Reinhold VN, Silveira DM, Chadwick M, Yesair DW (1978) Characterization of the metabolites of ellipticine in rat bile. Drug Metab Dispos 6:542\u2013548","journal-title":"Drug Metab Dispos"},{"key":"15_CR6","first-page":"C77","volume":"20","author":"A Brugarolas","year":"1979","unstructured":"Brugarolas A, Gracia M, De Jager R, Mallarmen M, Clarysse A (1979) Hydroxy methyl ellipticinium (9 HME, NSC 264137). Phase I clinical study. Proc 17th Annu Meet Am Assoc Cancer Res 20: C77","journal-title":"Proc 17th Annu Meet Am Assoc Cancer Res"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0090-9556(25)06289-0","volume":"6","author":"M Chadwick","year":"1978","unstructured":"Chadwick M, Silveira DM, Platz BB, Hayes D (1978) Comparative physiological disposition of ellipticine in several animal species after intravenous administration. Drug Metab Dipos 6:528\u2013541","journal-title":"Drug Metab Dipos"},{"key":"15_CR8","first-page":"1139","volume":"281","author":"J Cros","year":"1975","unstructured":"Cros J, Thibault A, Dat-Xuong N (1975) Action anti-inflammatoire de l\u2019hydroxy 9 ellipticine. CR Acad Sci [D] Paris 281:1139\u20131142","journal-title":"CR Acad Sci [D] Paris"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1071\/CH9672715","volume":"20","author":"LK Dalton","year":"1967","unstructured":"Dalton LK, Demerac S, Elmes BC, Loder JW, Swan JM, Teitei T (1967) Synthesis of the tumour-inhibitory alkaloids ellipticine 9-methoxy ellipticine and related pyrido (4,3-6) carbazoles. Aust J Chem 20:2715\u20132727","journal-title":"Aust J Chem"},{"key":"15_CR10","first-page":"441","volume":"31","author":"J Dufer","year":"1973","unstructured":"Dufer J, Desplaces A, Aurousseau M (1973) Etude cytochimique des leucocytes de rats traites par la methoxy 9 ellipticine. Ann Pharm Fr 31:441\u2013450","journal-title":"Ann Pharm Fr"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0014-5793(71)80176-X","volume":"17","author":"B Festy","year":"1971","unstructured":"Festy B, Poisson J, Paoletti C (1971) A new intercalating drug: Methoxy 9 ellipticine. FEBS Lett 17:321\u2013323","journal-title":"FEBS Lett"},{"key":"15_CR12","first-page":"539","volume":"15","author":"E Garcia-Giralt","year":"1970","unstructured":"Garcia-Giralt E, Macieira-Coelho A (1970) Methoxy 9 ellipticine. II. Analysis in vitro of the mechanism of action. Eur J Clin Biol Res 15:539\u2013544","journal-title":"Eur J Clin Biol Res"},{"key":"15_CR13","first-page":"63","volume":"58","author":"A Goldin","year":"1974","unstructured":"Goldin A, Johnson RK (1974) Evaluation of actinomycin in experimental systems. Cancer Chemother Rep 58:63\u201377","journal-title":"Cancer Chemother Rep"},{"key":"15_CR14","first-page":"523","volume":"67","author":"K Handa","year":"1976","unstructured":"Handa K, Sato S (1976) Stimulation of microsomal NADPH oxidation by quinone group containing anticancer chemicals. Gann 67:523\u2013528","journal-title":"Gann"},{"key":"15_CR15","first-page":"1884","volume":"32","author":"CT Hardesty","year":"1972","unstructured":"Hardesty CT, Chaney NA, Mead JAR (1972) The effect of route of administration of the distribution of ellipticine in mice. Cancer Res 32:1884\u20131889","journal-title":"Cancer Res"},{"key":"15_CR16","first-page":"117","volume-title":"Advances in pharmacology and chemotherapy, vol 7","author":"JL Hartwell","year":"1969","unstructured":"Hartwell JL, Abbotth BJ (1969) Antineoplastic principles in plants: Recent development in the field. In: Garrattini S, Goldin A, Hawking F, Kopin IJ (eds) Advances in pharmacology and chemotherapy, vol 7. Academic, New York, pp 117\u2013209"},{"key":"15_CR17","first-page":"101","volume":"21","author":"M Hayat","year":"1974","unstructured":"Hayat M, Mathe G, Janot MM, Potier P, Dat-Xuong N, Cave A, Sevenet T, Kan-Fan C, Poisson J, Miet J, Le Men J, Le Goffic F, Gouyette A, Ahond A, Dalton LK, Connors TA (1974) Experimental screening of 3 forms and 19 derivatives of analogs of ellipticine: Oncostatic effect on L1210 leukemia and immunosuppressive effect of 4 of them. Biomedicine 21:101\u2013106","journal-title":"Biomedicine"},{"key":"15_CR18","first-page":"637","volume":"58","author":"EH Herman","year":"1974","unstructured":"Herman EH, Chadwick DP, Mhatre RM (1974) Comparison of the acute hemolytic and cardiovascular actions of ellipticine (NSC 71795) and some ellipticine analogs. Cancer Chemother 58:637\u2013643","journal-title":"Cancer Chemother"},{"key":"15_CR19","first-page":"171","volume":"58","author":"EH Herman","year":"1974","unstructured":"Herman EH, Lee IP, Mhatre RM, Chadwick DP (1974) Prevention of hemolysis induced by ellipticine (NSC 71795) in rhesus monkeys. Cancer Chemother Rep 58:171\u2013179","journal-title":"Cancer Chemother Rep"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0041-008X(71)80029-7","volume":"18","author":"E Herman","year":"1971","unstructured":"Herman E, Vick J, Burka B (1971) The cardiovascular actions of ellipticine. Toxicol Appl Pharmacol 18:743\u2013751","journal-title":"Toxicol Appl Pharmacol"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2964(78)90180-9","volume":"14","author":"P Juret","year":"1978","unstructured":"Juret P, Tanguy A, Le Talaer JY, Abbatucci JS, Dat-Xuong N, Le Pecq J-B, Paoletti C (1978) Preliminary trial of 9-hydroxy 2-methyl ellipticinium (NSC 264137) in advanced human cancers. Eur J Cancer 14:205\u2013206","journal-title":"Eur J Cancer"},{"key":"15_CR22","first-page":"1495","volume":"8","author":"P Juret","year":"1979","unstructured":"Juret P, Tanguy A, Le Talaer JY, Abbatucci JS, Dat-Xuong N, Le Pecq J-B, Paoletti C (1979) L\u2019ac\u00e9tate d\u2019hydroxy 9-methyl 2-ellipticinium (NSC 264137). Etude toxicologique et th\u00e9rapeutique chez 100 canc\u00e9reux. Nouv Presse Med 8:1495\u20131498","journal-title":"Nouv Presse Med"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0009-2797(78)90086-8","volume":"20","author":"P Lecointe","year":"1978","unstructured":"Lecointe P, Lesca P, Cros S, Paoletti C (1978) Some antitumor derivatives of ellipticine deprived of mutagenic properties. Chem Biol Interact 20:113\u2013121","journal-title":"Chem Biol Interact"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0022-3565(25)30446-5","volume":"196","author":"IP Lee","year":"1976","unstructured":"Lee IP (1976) A possible mechanism of ellipticine induced hemolysis. J Pharmacol Exp Ther 196:525\u2013535","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR25","first-page":"534","volume":"15","author":"J Men Le","year":"1970","unstructured":"Le Men J, Hayat M, Math\u00e9 G, Guillon JC, Chenu E, Humbolt M, Masson Y (1970) Methoxy-9-ellipticine lactate. Experimental study (oncostatic and immunosuppressive actions: preclinical pharmacology). Rev Eur Etud Clin Biol 15:534\u2013538","journal-title":"Rev Eur Etud Clin Biol"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1073\/pnas.71.12.5078","volume":"71","author":"J-B Pecq Le","year":"1974","unstructured":"Le Pecq J-B, Dat-Xuong N, Gosse C, Paoletti C (1974) A new antitumoral agent: 9-Hydroxy ellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. Proc Natl Acad Sci USA 71:5078\u20135082","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR27","first-page":"3067","volume":"36","author":"J-B Pecq Le","year":"1976","unstructured":"Le Pecq J-B, Gosse C, Dat-Xuong N, Cros S, Paoletti C (1976) Antitumoral activity of 9 hydroxy ellipticine (NSC 210717) on L1210 mice leukemia. Effect of the route of injection. Cancer Res 36:3067\u20133076","journal-title":"Cancer Res"},{"key":"15_CR28","first-page":"1365","volume":"281","author":"J-B Pecq Le","year":"1975","unstructured":"Le Pecq J-B, Gosse C, Dat-Xuong N, Paoletti C (1975) Deux nouveaux derives antitumoraux: l\u2019hydroxy-9 methyl-2 ellipticinium et l\u2019hydroxy 9 dimethyl 2,6-ellipticinium. Action sur la leucemie L1210 de la souris. CR Acad Sci [D] Paris 281:1365\u20131367","journal-title":"CR Acad Sci [D] Paris"},{"key":"15_CR29","first-page":"1457","volume":"282","author":"P Lesca","year":"1976","unstructured":"Lesca P, Lecointe P, Paoletti C, Mansuy D (1976) Induction des monooxygenases hepatiques par Tellipticine chez le rat: formation de cytochrome P448. Activit\u00e9 hydroxylante. CR Acad Sci [D] Paris 282:1457\u20131460","journal-title":"CR Acad Sci [D] Paris"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/0006-2952(77)90270-2","volume":"26","author":"P Lesca","year":"1977","unstructured":"Lesca P, Lecointe P, Paoletti C, Mansuy D (1977) The hydroxylation of the antitumor agent ellipticine by liver microsomes from differently pretreated rats. Biochem Pharmacol 26:2169\u20132173","journal-title":"Biochem Pharmacol"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0006-2952(78)90453-7","volume":"27","author":"P Lesca","year":"1978","unstructured":"Lesca P, Lecointe P, Paoletti C, Mansuy D (1978) Ellipticine as potent inhibitors of aryl hydrocarbon hydroxylase: Their binding to microsomal cytochrome P450 and protective effect against benzo(a)pyrene mutagenicity. Biochem Pharmacol 27:1203\u20131209","journal-title":"Biochem Pharmacol"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0300-9084(78)80588-4","volume":"60","author":"P Lesca","year":"1978","unstructured":"Lesca P, Lecointe P, Paoletti C, Mansuy D (1978) Ellipticines as potent inhibitors of drug metabolism. Protective effect against chemical mutagenesis and carcinogenesis. Biochimie 60:1011\u20131018","journal-title":"Biochimie"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0009-2797(79)90007-3","volume":"24","author":"P Lesca","year":"1978","unstructured":"Lesca P, Rafidinarivo E, Lecointe P, Mansuy D (1978) A class of strong inhibitors of microsomal monooxygenases: The ellipticines. Chem Biol Interact 24:189\u2013198","journal-title":"Chem Biol Interact"},{"key":"15_CR34","first-page":"541","volume":"15","author":"G Math\u00e9","year":"1970","unstructured":"Math\u00e9 G, Hayat M, De Vassal F, Schwarzenberg L, Schneider M, Schlumberger JR, Jasmin C, Rosenfeld C (1970) Methoxy 9 ellipticine lactate. III. Clinical screening: Its action in acute myeloblasts leukemia. Rev Eur Etud Clin Biol 15:541\u2013545","journal-title":"Rev Eur Etud Clin Biol"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0022-2836(68)80024-5","volume":"35","author":"W Muller","year":"1968","unstructured":"Muller W, Crothers DM (1968) Studies of the binding of actinomycin and related compounds to DNA. J Mol Biol 35:251\u2013290","journal-title":"J Mol Biol"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0009-2797(79)90068-1","volume":"25","author":"C Paoletti","year":"1979","unstructured":"Paoletti C, Cros S, Dat-Xuong N, Lecointe P, Moisand A (1979) Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L1210 leukemia. Chem Biol Interact 25:45\u201358","journal-title":"Chem Biol Interact"},{"key":"15_CR37","first-page":"1195","volume-title":"Curr Chemother","author":"C Paoletti","year":"1978","unstructured":"Paoletti C, Le Pecq J-B, Dat-Xuong N, Lesca P, Lecointe P (1978) New anticancer derivatives in the ellipticine series. Curr Chemother 1195\u20131197"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0006-2952(79)90096-0","volume":"28","author":"C Paoletti","year":"1978","unstructured":"Paoletti C, Lesca C, Cros S, Malvy C, Auclair C (1978) Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. Biochem Pharmacol 28:345\u2013350","journal-title":"Biochem Pharmacol"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000136634","volume":"14","author":"Pham-Huu-Chanh","year":"1976","unstructured":"Pham-Huu-Chanh, Dat-Xuong N, Le Pecq J-B, Paoletti C (1976) Cardiovascular activity of 9 hydroxy ellipticine. Pharmacology 14:490\u2013498","journal-title":"Pharmacology"},{"key":"15_CR40","first-page":"1039","volume":"279","author":"Pham-Huu-Chanh","year":"1974","unstructured":"Pham-Huu-Chanh, Sorbara R, Dat-Xuong N, Paoletti C, Le Pecq J-B (1974) Actions cardiovasculaires et toxicites de l\u2019hydroxy 9 ellipticine chez le chien. CR Acad Sci [D] Paris 279:1039\u20131042","journal-title":"CR Acad Sci [D] Paris"},{"key":"15_CR41","first-page":"174","volume-title":"Acute toxicity of ellipticine (NSC 71795) following i.v. and p.o. administration to beagle dogs with special emphasis on its hypotensive action","author":"N Rakieten","year":"1970","unstructured":"Rakieten N, Cooney D, Davis R (1970) Acute toxicity of ellipticine (NSC 71795) following i.v. and p.o. administration to beagle dogs with special emphasis on its hypotensive action. US Dep Commer Natl Tech Inf Serv, PB 174\u2013743"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/bms.1200030612","volume":"3","author":"VN Reinhold","year":"1976","unstructured":"Reinhold VN, Bruni RJ (1976) Aromatic hydroxylation of ellipticine in rats: Lack of an NIH shift. Biomed Mass Spectrom 3:335\u2013339","journal-title":"Biomed Mass Spectrom"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-1977-24433","volume":"7","author":"M Sainsbury","year":"1977","unstructured":"Sainsbury M (1977) The synthesis of 6H-pyrido (4,3-b) carbazoles. Synthesis 7:437\u2013448","journal-title":"Synthesis"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/jps.2600571019","volume":"57","author":"GH Svoboda","year":"1968","unstructured":"Svoboda GH, Poore GA, Montfort M (1968) Alkaloids of ochrosia maculate {Ochrosia borbonica G mel). Isolation of the alkaloids and study of the antitumor properties of 9-methoxy ellipticine. J Pharm Sci 57:1720\u20131725","journal-title":"J Pharm Sci"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1021\/bi00721a002","volume":"13","author":"M Tomasz","year":"1974","unstructured":"Tomasz M, Mercado C, Olson J, Catterjie N (1974) The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry 13:4878\u20134887","journal-title":"Biochemistry"},{"key":"15_CR46","unstructured":"Van-Bac N, Moisand C, Gouyette A, Muzard G, Dat-Xuong N, Le Pecq J-B, Paoletti C (to be published) Metabolic and diposition studies of 9-hydroxy ellipticine and 2-methyl 9-hydroxy ellipticinium acetate in animals"},{"key":"15_CR47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)12624-2","volume":"4","author":"HL White","year":"1968","unstructured":"White HL, White JR (1968) Lethal action and metabolic effects of streptonigrin on Escherichia coli. Mol Pharmacol 4:549\u2013565","journal-title":"Mol Pharmacol"}],"container-title":["Recent Results in Cancer Research","Cancer Chemo- and Immunopharmacology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81488-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T21:28:54Z","timestamp":1741987734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-81488-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980]]},"ISBN":["9783642814907","9783642814884"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81488-4_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-81488-4","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[1980]]}}}